TIL therapy (tumor-infiltrating lymphocytes)

tumor-infiltrating lymphocytes (TIL) therapy

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TIL therapy (tumor-infiltrating lymphocytes), covering 2009-06-29 to 2025-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC [Phase 2]